Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CLEAR 2: SP-102 for Lumbosacral Radicular Pain
NCT07579351Phase 3Not yet recruiting
- Sponsor
- Semnur Pharmaceuticals, Inc.
- Start
- Feb 2027
- Primary completion
- Nov 2028
- Modality
- Hydrogel Systems, Small Molecules
01
Overview
A Phase 3 trial of semdexa in lumbosacral radiculopathy, sponsored by Semnur Pharmaceuticals, Inc.. Planned start Feb 2027; status: not yet recruiting.
02
Drugs
semdexa
03
Conditions
lumbosacral radiculopathy
Beyond the preview
Go deeper on NCT07579351.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07579351.